Clinerion Launches Patient Recruitment System to Substantially Boost Clinical Trial Recruitment

Clinerion formally launched its Patient Recruitment System (PRS) at the 8th Annual Optimizing Clinical Trials Summit in Barcelona. Clinerion’s PRS radically boosts recruitment for clinical trials, identifying 10 to 30 times more suitable candidates than those found through a classical manual screening approach, and in a matter of minutes rather than the weeks or months typically needed.

Speaking at the 8th Annual Optimizing Clinical Trials Summit in Barcelona, Ulf Claesson, CEO of Clinerion said: “Patient recruitment typically accounts for around 30% of the cost and time for clinical trials, yet more than 75% of studies fail to recruit their patients on time, costing the industry between $500,000 and $5 million in potential lost sales per day.”

“Results from the last 18 months shows our PRS can significantly speed up the recruitment process, offering a major opportunity for efficiency improvements and savings for the global pharmaceutical industry,” he added.

Founded in 2008, Swiss-based Clinerion is a worldwide leader in patient recruitment informatics. Using semantic and ontology methods, its automated PRS is designed to be used in countries with medical informatics infrastructures, where trials represent a major source of innovation and income for public and private hospitals, as well as healthcare systems.

The advantage of Clinerion’s system lies in its ability to identify suitable clinical study candidates for a given protocol through automated, simultaneous and real-time screening of multiple electronic health records. This system thus enables pharmaceutical companies to conduct feasibility analyses, as well as to quickly identify patients for study recruitment. The system includes coded information for diagnoses, treatments, medicines, etc. as well as for data such as lab values and information derived from sources such as free-text, including narratives and reports. Eligibility criteria can be mapped between standard medical and hospital-specific terminologies, while free-text is screened with the support of a natural language-processing function.

Clinerion’s PRS is available through an easy-to-use web-based application that can be employed for all disease indications and interventional trials in virtually all hospital systems, as well as in acute and outpatient settings.

About Clinerion
Clinerion provides leading software solutions to support pharmaceutical innovation, especially in the development of new medicines by life sciences companies and hospitals. Clinerion is a Swiss-based software and services company with operations in the US, Switzerland and Turkey.